News

Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., July 12, 2022 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), an oncology company focused on developing next-generation…

2 years ago

Catalyst Pharmaceuticals Announces Settlement of U.S. Patent Litigation and Resolution of Litigation Challenging Ruzurgi® Approval with Jacobus Pharmaceutical

As Part of the Settlement, Catalyst has Acquired Certain of Jacobus’ Intellectual Property Rights, Including the U.S. and Mexico Rights…

2 years ago

Philips spotlights latest AI-powered, software-defined MR smart systems at ECR 2022

Philips SmartSpeed MR software shot July 12, 2022  Philips SmartSpeed AI-based software receives FDA 510(k) clearance, delivering breakthrough high-speed, high-resolution…

2 years ago

Mainz Biomed Today to Provide Corporate Update for First Half of 2022

Company to Host Webcast Today - July 12th - at 4.00pm ETBERKELEY, Calif. and MAINZ, Germany, July 12, 2022 (GLOBE…

2 years ago

Sirona Biochem Corporate Update

VANCOUVER, British Columbia, July 12, 2022 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“Sirona”) provides…

2 years ago

Vaccentis appoints Martin Munte as CEO and strengthens Board

Image of Vaccentis CEO Martin Munte, CEOMartin Munte has extensive leadership experience at Amgen, AstraZeneca and RocheStrengthening management after appointment…

2 years ago

LegoChem Biosciences and Glycotope Announce Research Collaboration and License Agreement for an Antibody for use as Antibody Drug Conjugate

Glycotope GlycotopeLegoChem Biosciences and Glycotope Announce Research Collaboration and License Agreement for an Antibody for use as Antibody Drug Conjugate…

2 years ago

Basilea announces Zevtera® (ceftobiprole) marketing authorization in Brazil

Basel/Allschwil, Switzerland, July 12, 2022 Basilea Pharmaceutica Ltd (SIX: BSLN), a commercial-stage biopharmaceutical company, announced today that its distribution partner…

2 years ago

Rexlemestrocel-L to be Highlighted at Maxim’s Panel on Late-Stage Advancements in Heart Failure Therapeutics and Management

NEW YORK, July 11, 2022 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory…

2 years ago

Annexon Closes $130 Million Private Placement Extending its Operating Runway into the Second Half of 2025

Proceeds Support Advancement of Broad Pipeline of Novel Complement Product Candidates for Diseases of the Body, Brain and EyeBRISBANE, Calif.,…

2 years ago